# United Exchange Corporation – FDA Inspection, Apr 6, 2018

Source: https://www.keypedia.com/records/fda_inspections/united-exchange-corporation/c06c4134-5adb-403c-9d8c-cc6619cdbb78
Source feed: FDA_Inspections

> FDA inspection 1047420 of United Exchange Corporation, April 06, 2018. Classification: Official Action Indicated (OAI). 4 citations under 21 CFR part 211. Form 483 issued. 1 other FDA inspection on record for this company.

---

## Details

- Record Type: FDA Inspection
- Inspection ID: 1047420
- Company Name: United Exchange Corporation
- Inspection Date: 2018-04-06
- Classification: Official Action Indicated (OAI)
- Classification Code: OAI
- Project Area: Drug Quality Assurance
- Product Type: Drugs
- Center: Human Drugs
- Office Name: Center for Drug Evaluation and Research
- Citation Count: 4
- Enforcement Type: WARNING_LETTER

## Related Documents

- [FDA Inspection 1041004 - 2018-02-14](https://www.keypedia.com/records/fda_inspections/united-exchange-corporation/f268d789-5b94-48f9-a23a-c30b99d623d5)

## Related Officers

- [Zachary A. Bogorad](https://www.keypedia.com/people/zachary-a-bogorad/ae582dcd-f893-44a5-98bd-0b55f401577b)

Company: https://www.keypedia.com/companies/united-exchange-corporation/5565fe37-7bdd-4783-9d61-1ee9ba0c97ba

Office: https://www.keypedia.com/offices/center-for-drug-evaluation-and-research/cd980d74-1cbf-4226-ba9a-9045324c236c